View Older Stories View More Recent Stories

May 27, 2020 08:00AM Novavax Expands Large-Scale Global Manufacturing Capacity
May 27, 2020 08:00AM Novavax Expands Large-Scale Global Manufacturing Capacity
May 26, 2020 05:53AM Novavax (NVAX) Begins Phase 1/2 Clinical Trial of COVID-19 Vaccine
May 25, 2020 04:30PM Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
May 25, 2020 04:30PM Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
May 11, 2020 04:06PM Novavax (NVAX) Announces $388M Funding from CEPI for COVID-19 Vaccine
May 11, 2020 04:05PM Novavax Reports First Quarter 2020 Financial Results
May 11, 2020 04:05PM Novavax Reports First Quarter 2020 Financial Results
May 11, 2020 04:02PM Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
May 11, 2020 04:02PM Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
May 11, 2020 11:53AM Novavax (NVAX) to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series
May 11, 2020 11:53AM Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series
May 11, 2020 11:52AM Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series
May 6, 2020 09:15AM Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 11, 2020
May 6, 2020 09:15AM Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 11, 2020
Apr 8, 2020 09:31AM Pre-Open Stock Movers 04/08: (GNMK) (NVAX) (APT) Higher; (TAL) (EHTH) (W) Lower (more...)
Apr 8, 2020 06:06AM Novavax (NVAX) Reports Identification of Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
Apr 8, 2020 06:00AM Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
Apr 8, 2020 06:00AM Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
Mar 31, 2020 05:37PM Emergent BioSolutions (EBS) Enters Agreement with Novavax (NVAX) to Manufacture NanoFlu
Mar 31, 2020 04:05PM Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™
Mar 31, 2020 04:05PM Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™
Mar 24, 2020 09:14AM Pre-Open Movers 03/24: (GSAT) (NVAX) (CTMX) Higher; (MIST) (BXRX) (HOTH) Lower (more...)
Mar 24, 2020 06:02AM Novavax (NVAX) Reports NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
Mar 24, 2020 06:00AM Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
Mar 24, 2020 06:00AM Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
Mar 11, 2020 04:17PM Novavax Reports Fourth Quarter and Full Year 2019 Financial Results
Mar 11, 2020 04:17PM Novavax Reports Fourth Quarter and Full Year 2019 Financial Results
Mar 11, 2020 10:45AM Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate
Mar 11, 2020 10:45AM Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate
Mar 10, 2020 06:01AM Emergent BioSolutions (EBS) Reports Development & Manufacturing Agreement With Novavax (NVAX) for Experimental Vaccine Candidate for Coronavirus Disease
Mar 10, 2020 05:59AM Novavax (NVAX) Secures $4M Funding from CEPI for COVID-19 Vaccine Development
Mar 10, 2020 05:30AM Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development
Mar 10, 2020 05:30AM Emergent BioSolutions Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus Disease
Mar 10, 2020 05:30AM Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development
Mar 10, 2020 05:30AM Emergent BioSolutions Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus Disease
Mar 5, 2020 04:05PM Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results on March 11, 2020
Mar 5, 2020 04:05PM Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results on March 11, 2020
Mar 2, 2020 09:24AM Pre-Open Stock Movers 03/02: (FTSV) (TRIL) (TWTR) Higher; (BIOC) (ENLV) (NVAX) Lower (more...)
Feb 26, 2020 09:27AM Novavax (NVAX) Advances Development of Novel COVID-19 Vaccine
Feb 26, 2020 09:27AM Novavax Advances Development of Novel COVID-19 Vaccine
Feb 26, 2020 09:27AM Novavax Advances Development of Novel COVID-19 Vaccine
Feb 25, 2020 04:50PM Novavax (NVAX) Preclinical NanoFlu Data Published in Vaccines
Feb 25, 2020 04:05PM Novavax’ Preclinical NanoFlu Data Published in Vaccines; Details Structural Basis for Broadly Neutralizing Immunity
Feb 25, 2020 04:05PM Novavax’ Preclinical NanoFlu Data Published in Vaccines; Details Structural Basis for Broadly Neutralizing Immunity
Jan 15, 2020 08:35AM Novavax (NVAX) Granted Fast Track Designation for NanoFlu in Older Adults
Jan 15, 2020 08:30AM Novavax Granted Fast Track Designation for NanoFlu in Older Adults
Jan 15, 2020 08:30AM Novavax Granted Fast Track Designation for NanoFlu in Older Adults
Jan 9, 2020 04:05PM Novavax to Present at the 38th Annual J.P. Morgan Healthcare Conference
Jan 9, 2020 04:05PM Novavax to Present at the 38th Annual J.P. Morgan Healthcare Conference
View More Recent Stories View Older Stories